Symptoms experienced after transcatheter arterial chemoembolization in patients with primary liver cancer: A network analysis

原发性肝癌患者经导管动脉化疗栓塞术后症状的网络分析

阅读:1

Abstract

OBJECTIVE: This study aimed to establish a symptom network for patients with primary liver cancer posttranscatheter arterial chemoembolization (TACE), identifying core and bridge symptoms. The goal is to provide a foundation for precise and comprehensive nursing interventions. METHODS: A total of 1207 post-TACE patients were included using a consecutive sampling method. Data collection involved a general information questionnaire, the Anderson Symptom Assessment Scale, and a primary liver cancer-specific symptom module. The symptom network was constructed using the R language. RESULTS: In the overall network, distress exhibited the highest strength (r(s) = 1.31) and betweenness (r(b) = 62). Fatigue had the greatest closeness (r(c) = 0.0043), while nausea and vomiting (r = 0.76 ± 0.02) had the highest marginal weights. Nausea had the highest bridge strength (r(bs) = 5.263). In the first-time TACE-treated symptom network, sadness (r(bs) = 5.673) showed the highest bridge strength, whereas in the non-first-time symptom network, fever (r(bs) = 3.061) had the highest bridge strength. CONCLUSIONS: Distress serves as a core symptom, and nausea acts as a bridge symptom after TACE treatment in liver cancer patients. Interventions targeting bridge symptoms should be tailored based on the number of treatments, enhancing the quality of symptom management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。